Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerry Gray

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical Ophthalmology (Auckland, N.Z.)|May 31, 2022
Real World Data Comparison of Standard Care vs SDM Laser Vision Protection Therapy for Prevention of Neovascular AMDJeffrey K Luttrull, Gerry Gray
Scientific Reports|October 4, 2023
Vision protection therapy for prevention of neovascular age-related macular degenerationJeffrey K Luttrull, Gerry Gray, Sathy V Bhavan
Journal of Biopharmaceutical Statistics|August 20, 2016
Statistical innovations in diagnostic device evaluationTinghui Yu, Qin Li, Gerry Gray, et al.
Pharmacoepidemiology and Drug Safety|April 24, 2015
Signal detection using change point analysis in postmarket surveillanceZhiheng Xu, Taha Kass-Hout, Colin Anderson-Smits, et al.
Journal of Cardiac Failure|October 19, 2005
Key issues in end point selection for heart failure trials: composite end pointsJames D Neaton, Gerry Gray, Bram D Zuckerman, et al.
Clinical Ophthalmology (Auckland, N.Z.)|August 27, 2025
Cyclodialysis Surgery for Glaucoma Management: A Systematic Review and Meta-Analysis of 100 Years of Clinical EvidenceRobert Stamper, Alex Huang, Carol Toris, et al.
International Journal of Radiation Biology|December 4, 2018
Role of a high throughput biodosimetry test in treatment prioritization after a nuclear incidentAviva R Jacobs, Timothy Guyon, Violetta Headley, et al.
JAMA Network Open|November 15, 2021
Pivotal Evaluation of an Artificial Intelligence System for Autonomous Detection of Referrable and Vision-Threatening Diabetic RetinopathyEli Ipp, David Liljenquist, Bruce Bode, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical Ophthalmology (Auckland, N.Z.)|May 31, 2022
Real World Data Comparison of Standard Care vs SDM Laser Vision Protection Therapy for Prevention of Neovascular AMDJeffrey K Luttrull, Gerry Gray
Scientific Reports|October 4, 2023
Vision protection therapy for prevention of neovascular age-related macular degenerationJeffrey K Luttrull, Gerry Gray, Sathy V Bhavan
Journal of Biopharmaceutical Statistics|August 20, 2016
Statistical innovations in diagnostic device evaluationTinghui Yu, Qin Li, Gerry Gray, et al.
Pharmacoepidemiology and Drug Safety|April 24, 2015
Signal detection using change point analysis in postmarket surveillanceZhiheng Xu, Taha Kass-Hout, Colin Anderson-Smits, et al.
Journal of Cardiac Failure|October 19, 2005
Key issues in end point selection for heart failure trials: composite end pointsJames D Neaton, Gerry Gray, Bram D Zuckerman, et al.
Clinical Ophthalmology (Auckland, N.Z.)|August 27, 2025
Cyclodialysis Surgery for Glaucoma Management: A Systematic Review and Meta-Analysis of 100 Years of Clinical EvidenceRobert Stamper, Alex Huang, Carol Toris, et al.
International Journal of Radiation Biology|December 4, 2018
Role of a high throughput biodosimetry test in treatment prioritization after a nuclear incidentAviva R Jacobs, Timothy Guyon, Violetta Headley, et al.
JAMA Network Open|November 15, 2021
Pivotal Evaluation of an Artificial Intelligence System for Autonomous Detection of Referrable and Vision-Threatening Diabetic RetinopathyEli Ipp, David Liljenquist, Bruce Bode, et al.
Pageof 1